Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study

The BRUISE CONTROL trial (Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial) demonstrated that a strategy of continued warfarin during cardiac implantable electronic device surgery was safe and reduced the incidence of clinically significant pocket hematoma (CSH). CSH was de...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2016-03, Vol.67 (11), p.1300-1308
Hauptverfasser:	Essebag, Vidal, Verma, Atul, Healey, Jeff S, Krahn, Andrew D, Kalfon, Eli, Coutu, Benoit, Ayala-Paredes, Felix, Tang, Anthony S, Sapp, John, Sturmer, Marcio, Keren, Arieh, Wells, George A, Birnie, David H
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Brazil - epidemiology Canada - epidemiology Cardiology Clinical trials Committees Confidence intervals Defibrillators, Implantable - adverse effects Equipment Failure Female Follow-Up Studies Hematoma - complications Hospitalization Humans Incidence Infection - epidemiology Infection - etiology Infections Male Mortality Pacemaker, Artificial - adverse effects Postoperative Hemorrhage - complications Risk Assessment Risk Factors Single-Blind Method Studies Surgery Time Factors Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!